Search research articles
Contact Us
Filters
Showing results (41-50 of 59) with videos related to
Page
of 6
Sort By:
Journal of Molecular Medicine (Berlin, Germany)
|
April 13, 2010
Thromboxane synthase expression and thromboxane A2 production in the atherosclerotic lesion
Anders Gabrielsen, Hong Qiu, Magnus Bäck, et al.
European Heart Journal
|
March 15, 2024
Recombinant human soluble domain of CD39L3 and ticagrelor: cardioprotective effects in experimental myocardial infarction
Gemma Vilahur, Monika Radike, Pablo Sutelman, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 16, 2006
Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability
Hong Qiu, Anders Gabrielsen, Hanna E Agardh, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
June 6, 2009
Dickkopf-1 enhances inflammatory interaction between platelets and endothelial cells and shows increased expression in atherosclerosis
Thor Ueland, Kari Otterdal, Tove Lekva, et al.
Atherosclerosis
|
February 15, 2011
12- and 15-lipoxygenases in human carotid atherosclerotic lesions: associations with cerebrovascular symptoms
Karl Gertow, Elena Nobili, Lasse Folkersen, et al.
Molecular Medicine (Cambridge, Mass.)
|
October 5, 2011
Unraveling divergent gene expression profiles in bicuspid and tricuspid aortic valve patients with thoracic aortic dilatation: the ASAP study
Lasse Folkersen, Dick Wågsäter, Valentina Paloschi, et al.
Journal of Internal Medicine
|
July 8, 2021
Arginase 1 is upregulated at admission in patients with ST-elevation myocardial infarction
John Tengbom, Sofia Cederström, Dinos Verouhis, et al.
Journal of the American Heart Association
|
July 26, 2024
Novel Relaxin Receptor RXFP1 Agonist AZD3427 in the Treatment of Heart Failure: A Phase 1a/b, First-in-Human, Randomized, Single-Blind, Placebo-Controlled Study
Kathleen Connolly, Richard George, Sami Omar, et al.
Circulation. Cardiovascular Genetics
|
June 22, 2010
Association of genetic risk variants with expression of proximal genes identifies novel susceptibility genes for cardiovascular disease
Lasse Folkersen, Ferdinand van't Hooft, Ekaterina Chernogubova, et al.
International Journal of Cardiology
|
July 16, 2022
Safety and efficacy of the 5-lipoxygenase-activating protein inhibitor AZD5718 in patients with recent myocardial infarction: The phase 2a FLAVOUR study
Eva Prescott, Oskar Angerås, David Erlinge, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 59) with videos related to
Sort By:
Page
of 6
Journal of Molecular Medicine (Berlin, Germany)
|
April 13, 2010
Thromboxane synthase expression and thromboxane A2 production in the atherosclerotic lesion
Anders Gabrielsen, Hong Qiu, Magnus Bäck, et al.
European Heart Journal
|
March 15, 2024
Recombinant human soluble domain of CD39L3 and ticagrelor: cardioprotective effects in experimental myocardial infarction
Gemma Vilahur, Monika Radike, Pablo Sutelman, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 16, 2006
Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability
Hong Qiu, Anders Gabrielsen, Hanna E Agardh, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
June 6, 2009
Dickkopf-1 enhances inflammatory interaction between platelets and endothelial cells and shows increased expression in atherosclerosis
Thor Ueland, Kari Otterdal, Tove Lekva, et al.
Atherosclerosis
|
February 15, 2011
12- and 15-lipoxygenases in human carotid atherosclerotic lesions: associations with cerebrovascular symptoms
Karl Gertow, Elena Nobili, Lasse Folkersen, et al.
Molecular Medicine (Cambridge, Mass.)
|
October 5, 2011
Unraveling divergent gene expression profiles in bicuspid and tricuspid aortic valve patients with thoracic aortic dilatation: the ASAP study
Lasse Folkersen, Dick Wågsäter, Valentina Paloschi, et al.
Journal of Internal Medicine
|
July 8, 2021
Arginase 1 is upregulated at admission in patients with ST-elevation myocardial infarction
John Tengbom, Sofia Cederström, Dinos Verouhis, et al.
Journal of the American Heart Association
|
July 26, 2024
Novel Relaxin Receptor RXFP1 Agonist AZD3427 in the Treatment of Heart Failure: A Phase 1a/b, First-in-Human, Randomized, Single-Blind, Placebo-Controlled Study
Kathleen Connolly, Richard George, Sami Omar, et al.
Circulation. Cardiovascular Genetics
|
June 22, 2010
Association of genetic risk variants with expression of proximal genes identifies novel susceptibility genes for cardiovascular disease
Lasse Folkersen, Ferdinand van't Hooft, Ekaterina Chernogubova, et al.
International Journal of Cardiology
|
July 16, 2022
Safety and efficacy of the 5-lipoxygenase-activating protein inhibitor AZD5718 in patients with recent myocardial infarction: The phase 2a FLAVOUR study
Eva Prescott, Oskar Angerås, David Erlinge, et al.
Page
of 6